English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Other

Dysregulating ClpP: From Antibiotics to Anticancer?

MPS-Authors
There are no MPG-Authors available
External Resource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Dougan, D. A., Hantke, I., & Turgay, K. (2018). Dysregulating ClpP: From Antibiotics to Anticancer?.


Cite as: http://hdl.handle.net/21.11116/0000-0008-7D30-6
Abstract
In this issue of Cell Chemical Biology, Wong et al. (2018) identify several dysregulators of a key mitochondrial protease: casein lytic protease P (ClpP). These dysregulators were found to trigger programmed cell death and may offer fresh avenues for the development of novel cancer therapeutics.